Stealth BioTherapeutics Reports Received Orphan Drug Designation For Elamipretide For Treatment Of Duchenne Muscular Dystrophy; BZ NOTE: A Listing On The FDA's AccessData.gov Wednesday Showed This Information
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.